Hong Kong stocks fluctuate | HIT Genomics Group Medicine-B (06628.HK) rose nearly 4% recently received HiCB's external authorized milestone payment CDMO business steadily progressing

Zhizhong Financial APP learned that HEC Pharm Group Medicine-B (06628.HK) rose nearly 4%, as of the time of submission, it rose by 3.77% to 1.1 Hong Kong dollars, with a turnover of 136,300 Hong Kong dollars.